Effects of ketotifen upon responses to platelet activating factor: a basis for asthma prophylaxis.
Morley
J
J
Page
C P
CP
Mazzoni
L
L
Sanjar
S
S
D000420:Albuterol / Q000627:therapeutic use; D001249:Asthma / Q000517:prevention & control*; D004205:Cromolyn Sodium / Q000627:therapeutic use; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy; D007275:Injections, Intravenous; D007665:Ketotifen / Q000494:pharmacology*; D008168:Lung / Q000473:pathology; D008407:Mast Cells / Q000502:physiology; D010972:Platelet Activating Factor / Q000008:administration & dosage / Q000502:physiology*; D010974:Platelet Aggregation / Q000187:drug effects; D013806:Theophylline / Q000627:therapeutic use; D013997:Time Factors
D010972:Platelet Activating Factor; D013806:Theophylline; D004205:Cromolyn Sodium; D000420:Albuterol; D007665:Ketotifen